MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

First Posted Date
2014-09-29
Last Posted Date
2015-10-07
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT02251613

Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan

Not Applicable
Completed
Conditions
Corneal Staining
Interventions
Device: Opti-Free Plus
Device: FID 109182
Device: Senofilcon A contact lens
First Posted Date
2014-09-29
Last Posted Date
2015-06-10
Lead Sponsor
Alcon Research
Target Recruit Count
36
Registration Number
NCT02251561

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients

Not Applicable
Completed
Conditions
Glaucoma
Interventions
Device: Ex-PRESS® Glaucoma Filtration Device, Model P50PL
First Posted Date
2014-09-23
Last Posted Date
2018-07-20
Lead Sponsor
Alcon Research
Target Recruit Count
32
Registration Number
NCT02246777
Locations
🇯🇵

Contact Alcon Japan, Ltd for Trial Locations, Tokyo, Japan

DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance

Not Applicable
Completed
Conditions
Refractive Error
Presbyopia
Interventions
Device: Nelfilcon A MF contact lenses (DACP MF)
Device: Nelfilcon A single vision contact lenses (DACP)
First Posted Date
2014-09-10
Last Posted Date
2016-07-11
Lead Sponsor
Alcon Research
Target Recruit Count
24
Registration Number
NCT02235831

Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: Clear clip-on glasses
Device: ACRYSOF® IQ IOL
Device: Blue light filter clip-on glasses
Device: Clear IOL
First Posted Date
2014-08-19
Last Posted Date
2016-05-26
Lead Sponsor
Alcon Research
Target Recruit Count
90
Registration Number
NCT02219997

Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses

Not Applicable
Completed
Conditions
Presbyopia
Interventions
Device: Lotrafilcon B MF
Device: Lotrafilcon B MV
Device: Lotrafilcon B SVD
Device: Comfilcon A MF
Device: Habitual contact lenses
First Posted Date
2014-07-15
Last Posted Date
2016-02-18
Lead Sponsor
Alcon Research
Target Recruit Count
33
Registration Number
NCT02189863

Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses

Not Applicable
Completed
Conditions
Presbyopia
Corneal Astigmatism
Cataract
Interventions
Device: AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL
First Posted Date
2014-06-27
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
37
Registration Number
NCT02176343

A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Phemfilcon A contact lenses with color printing
Device: Lotrafilcon B contact lenses with color printing
First Posted Date
2014-06-26
Last Posted Date
2015-10-14
Lead Sponsor
Alcon Research
Target Recruit Count
151
Registration Number
NCT02175199

DW Evaluation of Lotrafilcon B Lenses in a Modified Design

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Lotrafilcon B sphere contact lenses
Device: Lotrafilcon B sphere modified design contact lenses
First Posted Date
2014-06-06
Last Posted Date
2015-08-11
Lead Sponsor
Alcon Research
Target Recruit Count
134
Registration Number
NCT02157909

6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
Ocular Hypertension
Glaucoma
Interventions
Drug: Dose Level B / Brinzolamide 1% ophthalmic suspension
Drug: Dose Level A / Brinzolamide 1% ophthalmic suspension
Drug: Dose Level C / Brinzolamide 1% ophthalmic suspension
First Posted Date
2014-05-16
Last Posted Date
2015-12-29
Lead Sponsor
Alcon Research
Target Recruit Count
327
Registration Number
NCT02140060
© Copyright 2025. All Rights Reserved by MedPath